DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in PFE — Pfizer Inc
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$30,002,353
-$7,666,150 QoQ
Shares Held
1,245,945
-7.1% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#226
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 66%
Shared 0%
None 34%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Jun 30, 2026CallValue
$63,715,680
CallShares
2,646,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $6,628,918,596 across 11 Drug Manufacturers - General names. PFE ranks #9 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
11,720,479 | $2,222,437,225 | |
| 2 | LLY |
ELI LILLY & Co
|
1,338,915 | $1,605,934,947 | |
| 3 | JNJ |
Johnson & Johnson
|
5,378,305 | $1,365,928,118 | |
| 4 | ABBV |
AbbVie Inc.
|
2,885,557 | $726,121,560 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,628,110 | $332,035,416 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,506,793 | $193,622,900 | |
| 7 | AMGN |
Amgen Inc
|
278,356 | $100,798,272 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
895,583 | $51,603,492 |
All Filings in PFE
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,715,680 | 2,646,000 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $30,002,353 | 1,245,945 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $37,668,503 | 1,341,471 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $760,316,544 | 27,076,800 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $31,699,417 | 1,273,069 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $63,642,464 | 2,497,742 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $45,550,473 | 1,879,145 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $40,252,282 | 1,588,488 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $37,892,028 | 1,428,271 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $40,547,340 | 1,401,083 | Shares | Defined | 2026-05-04 | |
| 2024-06-30 | $40,073,709 | 1,432,227 | Shares | Defined | 2026-05-04 | |
| 2024-03-31 | $21,782,250 | 784,946 | Shares | Defined | 2026-05-04 | |
| 2023-12-31 | $59,411,791 | 2,063,626 | Shares | Defined | 2026-05-04 | |
| 2023-09-30 | $53,294,701 | 1,606,714 | Shares | Defined | 2026-05-04 | |
| 2023-06-30 | $37,909,438 | 1,033,518 | Shares | Defined | 2026-05-04 | |
| 2023-03-31 | $41,258,670 | 1,011,242 | Shares | Defined | 2026-05-04 | |
| 2022-12-31 | $202,593,017 | 3,953,806 | Shares | Defined | 2026-05-04 | |
| 2022-09-30 | $345,818,736 | 7,902,622 | Shares | Defined | 2026-05-04 | |
| 2022-06-30 | $309,292,535 | 5,899,152 | Shares | Defined | 2026-05-04 | |
| 2022-06-30 | $26,215,000 | 500,000 | Call | Defined | 2026-05-04 | |
| 2022-03-31 | $109,644,870 | 2,117,923 | Shares | Defined | 2026-05-04 | |
| 2021-12-31 | $724,868,154 | 12,275,498 | Shares | Defined | 2026-05-04 | |
| 2021-09-30 | $77,407,201 | 1,799,749 | Shares | Defined | 2026-05-04 | |
| 2021-06-30 | $84,105,928 | 2,147,751 | Shares | Defined | 2026-05-04 | |
| 2021-03-31 | $40,523,326 | 1,118,502 | Shares | Sole | 2026-05-04 | |
| 2020-12-31 | $48,309,074 | 1,312,390 | Shares | Defined | 2026-05-04 | |
| 2020-09-30 | $53,779,610 | 1,465,386 | Shares | Defined | 2026-05-04 | |
| 2020-06-30 | $48,166,655 | 1,472,985 | Shares | Defined | 2026-05-04 | |
| 2020-03-31 | $47,267,614 | 1,448,152 | Shares | Defined | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||